Cargando…
Unsuccessful Treatment with Abatacept in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation
Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation occurs in up to 20–50% of FSGS patients and is associated with inferior allograft survival. Treatment of both primary FSGS as well as recurrent FSGS after transplantation with plasma exchange and immunosuppression is...
Autores principales: | Kristensen, Tilde, Ivarsen, Per, Povlsen, Johan Vestergaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301131/ https://www.ncbi.nlm.nih.gov/pubmed/28203563 http://dx.doi.org/10.1159/000454947 |
Ejemplares similares
-
Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis
por: Sprenger-Mähr, Hannelore, et al.
Publicado: (2016) -
HLA Loci and Recurrence of Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplantation
por: Shaw, Brian I., et al.
Publicado: (2021) -
Disease Recurrence—The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis
por: Kienzl-Wagner, Katrin, et al.
Publicado: (2019) -
UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant
por: Reynolds, Ben C., et al.
Publicado: (2021) -
Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation
por: Beaudreuil, Severine, et al.
Publicado: (2019)